Cargando…
[(18)F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment
The ability to assess tumor apoptotic response to therapy could provide a direct and prompt measure of therapeutic efficacy. (18)F-labeled 2-(5-fluoro-pentyl)-2-methyl-malonic acid ([(18)F]ML-10) is proposed as a positron emission tomography (PET) apoptosis imaging radiotracer. This manuscript prese...
Autores principales: | Oborski, Matthew J., Laymon, Charles M., Lieberman, Frank S., Qian, Yongxian, Drappatz, Jan, Mountz, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Grapho Publications, LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037921/ https://www.ncbi.nlm.nih.gov/pubmed/30042965 http://dx.doi.org/10.18383/j.tom.2016.00175 |
Ejemplares similares
-
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
por: Oborski, Matthew J, et al.
Publicado: (2014) -
Preclinical Evaluation of (18)F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors
por: Demirci, Emre, et al.
Publicado: (2017) -
SPECT Imaging of Epilepsy: An Overview and Comparison with F-18 FDG PET
por: Kim, Sunhee, et al.
Publicado: (2011) -
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods
por: Ahmed, Rafay, et al.
Publicado: (2014) -
Interest and Limits of [(18)F]ML-10 PET Imaging for Early Detection of Response to Conventional Chemotherapy
por: Jouberton, Elodie, et al.
Publicado: (2021)